SB-200646
SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A.[1]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H14N4O |
Molar mass | 302.76 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- Kennett, GA; Wood, MD; Glen, A; Grewal, S; Forbes, I; Gadre, A; Blackburn, TP (1994), "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist", Br J Pharmacol, British Journal of Pharmacology, 111: 797–802, doi:10.1111/j.1476-5381.1994.tb14808.x, PMC 1910094, PMID 7912626
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.